Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Data Collection
2.3. Operationalization of ACS Guidelines
ACS Guidelines for Cancer Survivors | Sub-Guidelines | Operationalization | Scoring | |
---|---|---|---|---|
| If overweight or obese, limit consumption of high-calorie foods and beverages and increase physical activity to promote weight loss. | BMI (kg/m2) | ||
18.5–22.9 | 2 | |||
23-25 | 1 | |||
<18.5 or >25 | 0 | |||
| Avoid inactivity and return to normal daily activities as soon as possible following diagnosis. Aim to exercise at least 150 min per week. Include strength training exercises at least 2 days per week. | METs (h/week) | ||
Tertile 3 (>40.3) | 2 | |||
Tertile 2 (19.6–43.3) | 1 | |||
Tertile 1 (<19.6) | 0 | |||
|
| Fruits and vegetables intake (g/day) | ||
Tertile 3 (>659.2) | 2 | Tertiles High 2 Middle 1 Low 0 | ||
Tertile 2 (443.1–659.2) | 1 | |||
Tertile 1 (<443.1) | 0 | |||
| Percentage of grains consumed as whole grains (%) | |||
Tertile 3 (90–100) | 2 | |||
Tertile 2 (64.3–90) | 1 | |||
Tertile 1 (0–64.3) | 0 | |||
| Red and processed meat intake (g/day) | |||
Tertile 1 (<5) | 2 | |||
Tertile 2 (5–60.7) | 1 | |||
Tertile 3 (>60.7) | 0 |
2.4. Operationalization of WCRF/AICR Recommendations
WCRF/AICR Recommendations for Cancer Survivors | Sub-Recommendations | Operationalization | Scoring | |
---|---|---|---|---|
|
| BMI (kg/m2) | ||
18.5–22.9 | 2 | |||
23-25 | 1 | |||
<18.5 or >25 | 0 | |||
|
| Physical activity (MET-hour/week) | ||
Tertile 3 (>40.3) | 2 | |||
Tertile 2 (19.6–43.3) | 1 | |||
Tertile 1 (<19.6) | 0 | |||
|
| Energy dense diet 1 (kcal/100 g) | Tertiles High 2 Middle 1 Low 0 | |
Tertile 1 (<154.2) | 2 | |||
Tertile 2 (132–154.2) | 1 | |||
Tertile 3 (>132) | 0 | |||
Sugary drinks (g/day) | ||||
None | 2 | |||
≤50 | 1 | |||
>50 | 0 | |||
|
| Non-starchy vegetable and fruit intake (g/day) | Tertiles High 2 Middle 1 Low 0 | |
Tertile 3 (>586.2) | 2 | |||
Tertile 2 (371.5–586.2) | 1 | |||
Tertile 1 (<371.5) | 0 | |||
Refined grains (g/day) | ||||
Tertile 1 (<15) | 2 | |||
Tertile 2 (15–45) | 1 | |||
Tertile 3 (>45) | 0 | |||
|
| Red meat and processed meat intake (g/day) | ||
Tertile 1 (<5) | 2 | |||
Tertile 2 (5–60.5) | 1 | |||
Tertile 3 (>60.5) | 0 | |||
|
| Sodium intake (mg/day) | ||
Tertile 1 (<3521.7) | 2 | |||
Tertile 2 (3521.7–4602.2) | 1 | |||
Tertile 3 (>4602.2) | 0 |
2.5. Health-Related Quality of Life Measurement
2.6. Statistical Analyses
3. Results
ACS Guidelines Score | WCRF/AICR Recommendation Score | ||||
---|---|---|---|---|---|
Characteristic | All (n = 160) | Q1 (n = 50) | Q4 (n = 48) | Q1 (n = 40) | Q4 (n = 33) |
Age, mean ± SD (year) | 50.96 ± 8.72 | 51.78 ± 6.84 | 52.75 ± 8.45 | 50.50 ± 9.09 | 50.76 ± 8.54 |
Body mass index, mean ± SD (kg/m2) | 22.58 ± 2.84 | 24.19 ± 3.57 | 21.25 ± 1.39 | 24.36 ± 3.44 | 21.41 ± 1.50 |
Physical activity, mean ± SD (MET-hour/week) | 37.88 ± 37.78 | 16.19 ± 22.74 | 58.07 ± 40.16 | 15.26 ± 11.59 | 52.56 ± 34.67 |
Education level, n (%) 1 | |||||
High school or below | 90 (56.25) | 25 (50.00) | 29 (60.42) | 20 (50.00) | 17 (51.52) |
College or above | 68 (42.50) | 25 (50.00) | 18 (37.50) | 20 (50.00) | 15 (45.45) |
Marital status, n (%) 1 | |||||
Married or cohabitation | 135 (84.38) | 41 (82.00) | 40 (83.33) | 30 (75.00) | 29 (87.88) |
Unmarried or divorced or widowed | 24 (15.00) | 9 (18.00) | 8 (16.67) | 10 (25.00) | 4 (12.12) |
Current menopausal status, n (%) 1 | |||||
Premenopausal | 16 (10.00) | 5 (10.00) | 1 (2.08) | 5 (12.50) | 3 (9.09) |
Postmenopausal | 137 (85.63) | 43 (86.00) | 44 (91.67) | 35 (87.50) | 29 (87.88) |
Time since surgery, n (%) | |||||
6 month–<1 year | 26 (16.25) | 8 (16.00) | 8 (16.67) | 7 (17.50) | 3 (9.09) |
1 year–<2 years | 65 (40.63) | 17 (34.00) | 24 (50.00) | 15 (37.50) | 18 (54.55) |
2 years–<5 years | 43 (26.88) | 14 (28.00) | 11 (22.92) | 9 (22.50) | 8 (24.24) |
≥5 years | 26 (16.25) | 11 (22.00) | 5 (10.42) | 9 (22.50) | 4 (12.12) |
AJCC stage at diagnosis, n (%) | |||||
I | 73 (45.63) | 21 (42.00) | 24 (50.00) | 20 (50.00) | 16 (48.48) |
II | 70 (43.75) | 22 (44.00) | 19 (39.58) | 14 (35.00) | 15 (45.45) |
III | 17 (10.63) | 7 (14.00) | 5 (10.42) | 6 (15.00) | 2 (6.06) |
Estrogen receptor status, n (%) 1 | |||||
Negative | 49 (30.63) | 14 (28.00) | 17 (35.42) | 8 (20.00) | 12 (36.36) |
Positive | 108 (67.50) | 34 (68.00) | 30 (62.50) | 31 (77.50) | 21 (63.64) |
Progesterone receptor status, n (%) 1 | |||||
Negative | 70 (43.75) | 19 (38.00) | 21 (43.75) | 17 (42.50) | 16 (48.48) |
Positive | 87 (54.38) | 29 (58.00) | 26 (54.17) | 22 (55.00) | 17 (51.52) |
Energy intake, mean ± SD (kcal/day) | 1749.59 ± 380.37 | 1676.96 ± 319.93 | 1871.90 ± 413.24 | 1779.77 ± 375.23 | 1796.31 ± 435.29 |
Dietary supplement use, n (%) | |||||
No | 56 (35.00) | 17 (34.00) | 12 (25.00) | 17 (42.50) | 8 (24.24) |
Yes | 104 (65.00) | 33 (66.00) | 36 (75.00) | 23 (57.50) | 25 (75.76) |
Alcohol intake, n (%) 1 | |||||
Never drinker | 76 (47.50) | 28 (56.00) | 24 (50.00) | 19 (47.50) | 15 (45.45) |
Ever drinker | 83 (51.88) | 22 (44.00) | 23 (47.92) | 21 (52.50) | 18 (54.55) |
Smoking status, n (%) 1 | |||||
Never smoker | 139 (86.88) | 45 (90.00) | 36 (75.00) | 36 (90.00) | 26 (78.79) |
Ever smoker | 5 (3.13) | 1 (2.00) | 2 (4.17) | 2 (5.00) | 1 (3.03) |
ACS Guidelines Score | ||||||
---|---|---|---|---|---|---|
HRQOL Items | n | Q1 (n = 50) | Q2 (n = 32) | Q3 (n = 30) | Q4 (n = 48) | p for Trend 2 |
ACS score, range | 160 | 0–2 | 3 | 4 | 5–6 | |
EORTC QLQ-C30, LS means (95% CI) | ||||||
Global health status/QoL | 134 | 23.36 (15.32–35.62) | 30.73 (18.74–50.39) | 33.10 (19.08–57.44) | 25.19 (16.00–39.67) | 0.68 |
Functioning | ||||||
Physical Functioning | 158 | 75.67 (65.17–87.87) | 77.87 (65.48–92.59) | 83.99 (69.25–101.86) | 76.60 (65.13–90.09) | 0.74 |
Role Functioning | 160 | 63.64 (48.26–83.92) | 79.45 (56.88–110.98) | 105.76 (72.86–153.52) | 81.32 (59.63–110.89) | 0.07 |
Emotional Functioning | 160 | 71.80 (58.30–88.43) | 73.83 (57.41–94.96) | 60.06 (45.36–79.51) | 79.72 (63.11–100.70) | 0.67 |
Cognitive Functioning | 160 | 72.15 (61.40–84.79) | 71.48 (58.82–86.86) | 88.74 (71.40–110.29) | 66.52 (55.51–79.72) | 0.77 |
Social Functioning | 160 | 57.16 (46.21–70.69) | 64.57 (49.95–83.48) | 77.86 (58.47–103.67) | 71.06 (55.99–90.19) | 0.05 |
Symptom | ||||||
Fatigue | 159 | 27.30 (20.25–36.79) | 25.76 (18.12–36.62) | 19.77 (13.35–29.28) | 24.65 (17.74–34.24) | 0.37 |
Nausea and vomiting | 160 | 2.71 (1.59–4.62) | 2.93 (1.54–5.57) | 2.35 (1.15–4.82) | 2.60 (1.43–4.73) | 0.79 |
Pain | 159 | 10.26 (5.74–18.35) | 15.99 (8.06–31.72) | 6.79 (3.16–14.59) | 8.38 (4.42–15.89) | 0.28 |
Dyspnea | 158 | 4.84 (2.53–9.24) | 4.53 (2.11–9.71) | 4.20 (1.80–9.84) | 3.32 (1.63–6.78) | 0.32 |
Insomnia | 158 | 12.66 (6.94–23.09) | 17.57 (8.65–35.69) | 18.25 (8.27–40.28) | 21.30 (10.95–41.44) | 0.14 |
Loss of appetite | 158 | 2.48 (1.34–4.59) | 2.27 (1.10–4.68) | 3.08 (1.37–6.93) | 1.89 (0.96–3.73) | 0.59 |
Constipation | 158 | 6.92 (3.62–13.21) | 5.00 (2.34–10.65) | 6.96 (2.99–16.20) | 6.48 (3.19–13.14) | 0.99 |
Diarrhea | 160 | 3.83 (2.14–6.84) | 2.73 (1.35–5.50) | 2.76 (1.26–6.03) | 2.93 (1.53–5.62) | 0.45 |
Financial impact | 160 | 9.73 (5.17–18.29) | 7.18 (3.35–15.40) | 9.18 (3.92–21.49) | 5.70 (2.81–11.57) | 0.22 |
EORTC QLQ-BR23, LS means (95% CI) | ||||||
Functioning | ||||||
Body image | 160 | 42.54 (27.15–66.64) | 32.57 (18.94–56.01) | 48.20 (26.33–88.24) | 29.92 (18.08–49.50) | 0.35 |
Sexual functioning | 153 | 1.91 (1.03–3.55) | 2.70 (1.28–5.67) | 2.36 (1.05–5.30) | 4.01 (2.00–8.03) | 0.06 |
Future perspective | 160 | 36.99 (21.71–63.02) | 27.65 (14.53–52.64) | 43.67 (21.30–89.53) | 32.90 (18.10–59.82) | 0.95 |
Symptom | ||||||
Systematic therapy side effects | 160 | 21.95 (16.30–29.55) | 25.72 (17.95–36.84) | 19.12 (12.80–28.54) | 18.89 (13.53–26.36) | 0.26 |
Breast symptoms | 160 | 14.19 (8.71–23.11) | 12.32 (6.83–22.21) | 10.31 (5.35–19.89) | 11.08 (6.41–19.14) | 0.34 |
Arm symptoms | 160 | 19.25 (12.92–28.68) | 25.87 (15.99–41.87) | 20.03 (11.71–34.26) | 28.65 (18.32–44.79) | 0.17 |
Upset by hair loss | 101 | 23.78 (11.61–48.74) | 19.30 (8.45–44.07) | 18.83 (6.41–55.36) | 42.87 (18.83–97.59) | 0.20 |
WCRF/AICR Recommendation Score | ||||||
---|---|---|---|---|---|---|
HRQOL Items | n | Q1 (n = 40) | Q2 (n = 46) | Q3 (n = 41) | Q4 (n = 33) | p for Trend 2 |
WCRF/AICR score, range | 160 | 1–4 | 5–6 | 7–8 | 9–12 | |
EORTC QLQ-C30, LS means (95% CI) | ||||||
Global health status/QoL | 134 | 28.10 (18.45–42.79) | 24.41 (14.76–40.38) | 24.46 (15.37–38.92) | 30.15 (17.70–51.35) | 0.90 |
Functioning | ||||||
Physical Functioning | 158 | 76.29 (65.68–88.62) | 82.08 (69.05–97.58) | 78.00 (66.15–91.98) | 73.95 (61.33–89.16) | 0.63 |
Role Functioning | 160 | 68.05 (50.95–90.89) | 84.26 (60.64–117.08) | 77.20 (56.02–106.39) | 84.76 (58.87–122.05) | 0.44 |
Emotional Functioning | 160 | 70.61 (57.00–87.47) | 80.71 (63.27–102.94) | 75.44 (59.50–95.63) | 62.86 (48.00–82.32) | 0.41 |
Cognitive Functioning | 160 | 70.72 (59.80–83.63) | 77.45 (64.01–93.71) | 74.37 (61.76–89.56) | 64.81 (52.46–80.05) | 0.46 |
Social Functioning | 160 | 54.17 (43.64–67.25) | 77.34 (60.49–98.89) | 68.10 (53.59–86.54) | 76.71 (58.42–100.73) | 0.09 |
Symptom | ||||||
Fatigue | 159 | 24.81 (18.36–33.52) | 22.30 (15.67–31.74) | 27.73 (19.81–38.80) | 25.92 (17.69–37.97) | 0.45 |
Nausea and vomiting | 160 | 2.67 (1.55–4.62) | 2.41 (1.29–4.48) | 2.76 (1.51–5.05) | 3.09 (1.55–6.14) | 0.61 |
Pain | 159 | 11.07 (6.13–19.99) | 8.51 (4.25–17.02) | 11.01 (5.69–21.30) | 8.50 (4.02–18.00) | 0.81 |
Dyspnea | 158 | 4.86 (2.55–9.29) | 3.62 (1.69–7.73) | 4.63 (2.25–9.54) | 2.65 (1.17–6.03) | 0.39 |
Insomnia | 158 | 11.98 (6.59–21.78) | 18.84 (9.34–38.00) | 18.97 (9.73–36.99) | 29.80 (13.87–64.04) | 0.05 |
Loss of appetite | 158 | 2.12 (1.15–3.92) | 2.78 (1.36–5.71) | 2.94 (1.48–5.83) | 1.49 (0.68–3.27) | 0.61 |
Constipation | 158 | 6.99 (3.67–13.31) | 3.64 (1.72–7.69) | 7.45 (3.65–15.19) | 6.33 (2.82–14.22) | 0.52 |
Diarrhea | 160 | 4.35 (2.41–7.86) | 2.31 (1.18–4.53) | 2.39 (1.24–4.59) | 3.52 (1.67–7.42) | 0.57 |
Financial impact | 160 | 9.56 (5.00–18.26) | 5.68 (2.72–11.86) | 8.70 (4.24–17.83) | 5.44 (2.40–12.30) | 0.54 |
EORTC QLQ-BR23, LS means (95% CI) | ||||||
Functioning | ||||||
Body image | 160 | 37.58 (23.91–59.07) | 41.99 (25.12–70.21) | 44.50 (26.96–73.45) | 19.70 (11.15–34.83) | 0.13 |
Sexual functioning | 153 | 1.74 (0.92–3.27) | 3.57 (1.73–7.37) | 3.86 (1.93–7.71) | 2.23 (1.03–4.84) | 0.42 |
Future perspective | 160 | 39.37 (22.84–67.85) | 40.48 (21.80–75.15) | 28.91 (15.81–52.86) | 23.83 (12.00–47.31) | 0.10 |
Symptom | ||||||
Systematic therapy side effects | 160 | 24.14 (17.78–32.77) | 17.69 (12.50–25.04) | 20.63 (14.70–28.95) | 21.59 (14.69–31.73) | 0.86 |
Breast symptoms | 160 | 13.62 (8.26–22.47) | 11.63 (6.59–20.55) | 10.44 (6.00–18.18) | 15.16 (8.07–28.48) | 0.99 |
Arm symptoms | 160 | 18.09 (12.07–27.13) | 22.70 (14.32–35.98) | 27.16 (17.34–42.55) | 35.55 (21.34–59.23) | 0.01 |
Upset by hair loss | 101 | 24.21 (11.96–48.97) | 11.95 (4.80–29.77) | 29.39 (12.72–67.89) | 39.41 (16.07–96.68) | 0.10 |
4. Discussion
5. Conclusions
Supplementary Materials
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012. Int. J. Cancer 2015, 136, E359–E386. [Google Scholar] [CrossRef] [PubMed]
- American Cancer Society. Breast Cancer Facts & Figures 2013–2014; American Cancer Society, Inc.: Atlanta, GA, USA, 2013. [Google Scholar]
- Berry, D.A.; Cronin, K.A.; Plevritis, S.K.; Fryback, D.G.; Clarke, L.; Zelen, M.; Mandelblatt, J.S.; Yakovlev, A.Y.; Habbema, J.D.; Feuer, E.J.; et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 2005, 353, 1784–1792. [Google Scholar] [CrossRef] [PubMed]
- Jung, K.W.; Won, Y.J.; Kong, H.J.; Oh, C.M.; Cho, H.; Lee, D.H.; Lee, K.H. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2012. Cancer Res. Treat. 2015, 47, 127–141. [Google Scholar] [CrossRef] [PubMed]
- Demark-Wahnefried, W.; Aziz, N.M.; Rowland, J.H.; Pinto, B.M. Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J. Clin. Oncol. 2005, 23, 5814–5830. [Google Scholar] [CrossRef] [PubMed]
- World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective; AICR: Washington, DC, USA, 2007. [Google Scholar]
- World Cancer Research Fund. Diet, Nutrition, Physical Activity and Breast Cancer Survivors; World Cancer Research Fund International: London, UK, 2014. [Google Scholar]
- Rock, C.L.; Doyle, C.; Demark-Wahnefried, W.; Meyerhardt, J.; Courneya, K.S.; Schwartz, A.L.; Bandera, E.V.; Hamilton, K.K.; Grant, B.; McCullough, M.; et al. Nutrition and physical activity guidelines for cancer survivors. Cancer J. Clin. 2012, 62, 243–274. [Google Scholar] [CrossRef] [PubMed]
- Patterson, R.E.; Cadmus, L.A.; Emond, J.A.; Pierce, J.P. Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature. Maturitas 2010, 66, 5–15. [Google Scholar] [CrossRef] [PubMed]
- Hastert, T.A.; Beresford, S.A.; Patterson, R.E.; Kristal, A.R.; White, E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol. Biomark. Prev. 2013, 22, 1498–1508. [Google Scholar] [CrossRef] [PubMed]
- Romaguera, D.; Vergnaud, A.C.; Peeters, P.H.; van Gils, C.H.; Chan, D.S.; Ferrari, P.; Romieu, I.; Jenab, M.; Slimani, N.; Clavel-Chapelon, F.; et al. Is concordance with world cancer research fund/american institute for cancer research guidelines for cancer prevention related to subsequent risk of cancer? Results from the epic study. Am. J. Clin. Nutr. 2012, 96, 150–163. [Google Scholar] [CrossRef] [PubMed]
- Thomson, C.A.; McCullough, M.L.; Wertheim, B.C.; Chlebowski, R.T.; Martinez, M.E.; Stefanick, M.L.; Rohan, T.E.; Manson, J.E.; Tindle, H.A.; Ockene, J.; et al. Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women’s health initiative. Cancer Prev. Res. 2014, 7, 42–53. [Google Scholar] [CrossRef] [PubMed]
- Catsburg, C.; Miller, A.B.; Rohan, T.E. Adherence to cancer prevention guidelines and risk of breast cancer. Int. J. Cancer 2014, 135, 2444–2452. [Google Scholar] [CrossRef] [PubMed]
- Kabat, G.C.; Matthews, C.E.; Kamensky, V.; Hollenbeck, A.R.; Rohan, T.E. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: A prospective cohort study. Am. J. Clin. Nutr. 2015, 101, 558–569. [Google Scholar] [CrossRef] [PubMed]
- Blanchard, C.M.; Courneya, K.S.; Stein, K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the american cancer society’s scs-II. J. Clin. Oncol. 2008, 26, 2198–2204. [Google Scholar] [CrossRef] [PubMed]
- Inoue-Choi, M.; Robien, K.; Lazovich, D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol. Biomark. Prev. 2013, 22, 792–802. [Google Scholar] [CrossRef] [PubMed]
- Inoue-Choi, M.; Lazovich, D.; Prizment, A.E.; Robien, K. Adherence to the world cancer research fund/american institute for cancer research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors. J. Clin. Oncol. 2013, 31, 1758–1766. [Google Scholar] [CrossRef] [PubMed]
- Ainsworth, B.E.; Haskell, W.L.; Herrmann, S.D.; Meckes, N.; Bassett, D.R., Jr.; Tudor-Locke, C.; Greer, J.L.; Vezina, J.; Whitt-Glover, M.C.; Leon, A.S. 2011 compendium of physical activities: A second update of codes and met values. Med. Sci. Sports Exerc. 2011, 43, 1575–1581. [Google Scholar] [CrossRef] [PubMed]
- Ainsworth, B.E.; Herrmann, S.D.; Meckes, N.; Bassett, D.R., Jr.; Tudor-Locke, C.; Greer, J.L.; Vezina, J.; Whitt-Glover, M.C.; Leon, A.S. The Compendium of Physical Activities Tracking Guide. Availavble online: https://sites.google.com/site/compendiumofphysicalactivities/ (accessed on 1 May 2015).
- WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment; Health Communications Australia: Melbourne, Australia, 2000. [Google Scholar]
- Flatt, S.W.; Thomson, C.A.; Gold, E.B.; Natarajan, L.; Rock, C.L.; Al-Delaimy, W.K.; Patterson, R.E.; Saquib, N.; Caan, B.J.; Pierce, J.P. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol. Biomark. Prev. 2010, 19, 681–688. [Google Scholar] [CrossRef] [PubMed]
- Li, C.I.; Daling, J.R.; Porter, P.L.; Tang, M.T.C.; Malone, K.E. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J. Clin. Oncol. 2009, 27, 5312–5318. [Google Scholar] [CrossRef] [PubMed]
- Trentham-Dietz, A.; Newcomb, P.A.; Nichols, H.B.; Hampton, J.M. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res. Treat. 2007, 105, 195–207. [Google Scholar] [CrossRef] [PubMed]
- Kwan, M.L.; Kushi, L.H.; Weltzien, E.; Tam, E.K.; Castillo, A.; Sweeney, C.; Caan, B.J. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: The life after cancer epidemiology study. J. Clin. Oncol. 2010, 28, 4410–4416. [Google Scholar] [CrossRef] [PubMed]
- Saquib, J.; Rock, C.L.; Natarajan, L.; Saquib, N.; Newman, V.A.; Patterson, R.E.; Thomson, C.A.; al-Delaimy, W.K.; Pierce, J.P. Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer. Nutr. Cancer 2011, 63, 327–333. [Google Scholar] [CrossRef] [PubMed]
- Fleischauer, A.T.; Simonsen, N.; Arab, L. Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr. Cancer 2003, 46, 15–22. [Google Scholar] [CrossRef] [PubMed]
- Phillips, K.A.; Milne, R.L.; West, D.W.; Goodwin, P.J.; Giles, G.G.; Chang, E.T.; Figueiredo, J.C.; Friedlander, M.L.; Keegan, T.H.; Glendon, G.; et al. Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry. Cancer Epidemiol. Biomark. Prev. 2009, 18, 1792–1797. [Google Scholar] [CrossRef] [PubMed]
- Trivers, K.F.; Gammon, M.D.; Abrahamson, P.E.; Lund, M.J.; Flagg, E.W.; Kaufman, J.S.; Moorman, P.G.; Cai, J.; Olshan, A.F.; Porter, P.L.; et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res. Treat. 2007, 103, 93–102. [Google Scholar] [CrossRef] [PubMed]
- Alsaker, M.D.; Opdahl, S.; Asvold, B.O.; Romundstad, P.R.; Vatten, L.J. The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res. Treat. 2011, 130, 175–182. [Google Scholar] [CrossRef] [PubMed]
- Yun, Y.H.; Park, Y.S.; Lee, E.S.; Bang, S.M.; Heo, D.S.; Park, S.Y.; You, C.H.; West, K. Validation of the korean version of the EORTC QLQ-C30. Qual. Life Res. 2004, 13, 863–868. [Google Scholar] [CrossRef] [PubMed]
- Yun, Y.H.; Bae, S.H.; Kang, I.O.; Shin, K.H.; Lee, R.; Kwon, S.I.; Park, Y.S.; Lee, E.S. Cross-cultural application of the korean version of the european organization for research and treatment of cancer (EORTC) breast-cancer-specific quality of life questionnaire (EORTC QLQ-BR23). Support. Care Cancer 2004, 12, 441–445. [Google Scholar] [PubMed]
- Aaronson, N.K.; Bergman, B.; Bullinger, M.; Cull, A.; Duez, N.J.; Filiberti, A.; Flechtner, H.; Fleishman, S.B.; de Haes, J.C.J.M.; Kaasa, S.; et al. The european organisation for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 1993, 85, 365–376. [Google Scholar] [CrossRef] [PubMed]
- Fayers PM, A.N.; Bjordal, K.; Groenvold, M.; Curran, D.; Bottomley, A.; on behalf of the EORTC Quality of Life Group. The Eortc QLQ-C30 Scoring Manual, 3rd ed.; European Organisation for Research and Treatment of Cancer: Brussels, Belgium, 2001; pp. 55–58. [Google Scholar]
- Wayne, S.J.; Baumgartner, K.; Baumgartner, R.N.; Bernstein, L.; Bowen, D.J.; Ballard-Barbash, R. Diet quality is directly associated with quality of life in breast cancer survivors. Breast Cancer Res. Treat. 2006, 96, 227–232. [Google Scholar] [CrossRef] [PubMed]
- Mosher, C.E.; Sloane, R.; Morey, M.C.; Snyder, D.C.; Cohen, H.J.; Miller, P.E.; Demark-Wahnefried, W. Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer 2009, 115, 4001–4009. [Google Scholar] [CrossRef] [PubMed]
- Maunsell, E.; Drolet, M.; Brisson, J.; Robert, J.; Deschenes, L. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress. J. Clin. Oncol. 2002, 20, 1017–1025. [Google Scholar] [CrossRef] [PubMed]
- Zeng, Y.; Huang, M.; Cheng, A.S.; Zhou, Y.; So, W.K. Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors. Breast Cancer 2014, 21, 262–274. [Google Scholar] [CrossRef] [PubMed]
- Travier, N.; Fonseca-Nunes, A.; Javierre, C.; Guillamo, E.; Arribas, L.; Peiro, I.; Buckland, G.; Moreno, F.; Urruticoechea, A.; Oviedo, G.R.; et al. Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors. Med. Oncol. 2014, 31, 783. [Google Scholar] [CrossRef] [PubMed]
- Swisher, A.K.; Abraham, J.; Bonner, D.; Gilleland, D.; Hobbs, G.; Kurian, S.; Yanosik, M.A.; Vona-Davis, L. Exercise and dietary advice intervention for survivors of triple-negative breast cancer: Effects on body fat, physical function, quality of life, and adipokine profile. Support. Care Cancer 2015, 23, 2995–3003. [Google Scholar] [CrossRef] [PubMed]
- Lee, M.K.; Yun, Y.H.; Park, H.A.; Lee, E.S.; Jung, K.H.; Noh, D.Y. A web-based self-management exercise and diet intervention for breast cancer survivors: Pilot randomized controlled trial. Int. J. Nurs. Stud. 2014, 51, 1557–1567. [Google Scholar] [CrossRef] [PubMed]
- Goodwin, P.J.; Segal, R.J.; Vallis, M.; Ligibel, J.A.; Pond, G.R.; Robidoux, A.; Blackburn, G.L.; Findlay, B.; Gralow, J.R.; Mukherjee, S.; et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: The lisa trial. J. Clin. Oncol. 2014, 32, 2231–2239. [Google Scholar] [CrossRef] [PubMed]
- Mols, F.; Vingerhoets, A.J.J.M.; Coebergh, J.W.; van de Poll-Franse, L.V. Quality of life among long-term breast cancer survivors: A systematic review. Eur. J. Epidemiol. 2005, 41, 2613–2619. [Google Scholar] [CrossRef] [PubMed]
- Howard-Anderson, J.; Ganz, P.A.; Bower, J.E.; Stanton, A.L. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: A systematic review. J. Natl. Cancer Inst. 2012, 104, 386–405. [Google Scholar] [CrossRef] [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Song, S.; Hwang, E.; Moon, H.-G.; Noh, D.-Y.; Lee, J.E. Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors. Nutrients 2015, 7, 10307-10319. https://doi.org/10.3390/nu7125532
Song S, Hwang E, Moon H-G, Noh D-Y, Lee JE. Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors. Nutrients. 2015; 7(12):10307-10319. https://doi.org/10.3390/nu7125532
Chicago/Turabian StyleSong, Sihan, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, and Jung Eun Lee. 2015. "Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors" Nutrients 7, no. 12: 10307-10319. https://doi.org/10.3390/nu7125532
APA StyleSong, S., Hwang, E., Moon, H. -G., Noh, D. -Y., & Lee, J. E. (2015). Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors. Nutrients, 7(12), 10307-10319. https://doi.org/10.3390/nu7125532